Perfuze
Manufacturing · Ireland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Galway Business Park unit 6, Dangan Galw...Phone Number
+353 91428083Website
www.perfuze.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Perfuze
Perfuze, founded in 2018 and based in Galway, Ireland, is a private company focused on advancing stroke treatment. The company develops innovative catheter technology designed to enhance vessel access and improve clot removal during thrombectomy procedures. Their solutions address the unmet need for more effective and repeatable methods to treat ischemic strokes. Perfuze is committed to improving clinical outcomes for stroke patients through advanced medical technology in the medtech industry.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Perfuze your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Perfuze has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Perfuze launches new products
Check out if Perfuze is spiking on competitors!
Funding: Get notified immidiatlly once Perfuze has new funding data
Click to see if Perfuze had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Perfuze
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Perfuze, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Perfuze recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Perfuze is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Perfuze is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Perfuze.
Perfuze financials insights
Gather financial insights about Perfuze, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$2.4M
2022
Series A
$25.7M
2025
Unspecified
$23.8M
Perfuze Tech Stack
A closer look at the technologies used by Perfuze
See more technologies
Most Recent Scoops
Funding
Funding
Project
Product Management, Intellectual Property, Legal Affairs
Funding
Funding
Perfuze News & Media
Perfuze Announces Completion of Enrollment in Pivotal US Clinical Study and Appointment of Joe Rotger as Executive Vice President of Sales
GALWAY, Ireland--(BUSINESS WIRE)--Perfuze, a leader in next-generation catheter-based technology for the treatment of acute ischemic stroke, today announced two significant milestones in its mission to improve stroke care: 1) the completion of patient enrollment in its U.S. pivotal IDE clinical trial, MARRS (Millipede Aspiration for Revascularization in Stroke Study), and 2) the appointment of seasoned medtech executive Joe Rotger as Executive Vice President of Sales. The MARRS pivotal study, cPerfuze: €22 Million Raised And Clearance Received For Zipline Access Catheters
Perfuze, a leading medical device company dedicated to advancing stroke treatment, has received FDA 510(k) clearance for its Zipline Access Catheters. This milestone strengthens Perfuze’s growing portfolio of innovative neurovascular devices, enabling physicians to treat acute ischemic strokes rapidly, easily, and precisely. Plus, Perfuze has secured €22 million in follow-on funding in a round led by existing investors, including Earlybird, EQT Life Sciences, Seroba, and SV Health.Vento launches €75M Fund II, Curve raises €44M, Perfuze secures €22M and more
Recently, the tech industry has seen a lot of new advancements and updates.Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding
GALWAY, Ireland--(BUSINESS WIRE)-- #CompleteClotIngestion--Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Perfuze
Sign Up For FreeTo access detailed company insights
Perfuze, founded in 2018 and based in Galway, Ireland, is a private company focused on advancing stroke treatment. The company develops innovative catheter technology designed to enhance vessel access and improve clot removal during thrombectomy procedures. Their solutions address the unmet need for more effective and repeatable methods to treat is... Read More
